Large-scale application of high-throughput molecular mechanics with Poisson-Boltzmann surface area for routine physics-based scoring of protein-ligand complexes.

Article Details

Citation

Brown SP, Muchmore SW

Large-scale application of high-throughput molecular mechanics with Poisson-Boltzmann surface area for routine physics-based scoring of protein-ligand complexes.

J Med Chem. 2009 May 28;52(10):3159-65. doi: 10.1021/jm801444x.

PubMed ID
19385614 [ View in PubMed
]
Abstract

We apply a high-throughput formulation of the molecular mechanics with Poisson-Boltzmann surface area (htMM-PBSA) to estimate relative binding potencies on a set of 308 small-molecule ligands in complex with the proteins urokinase, PTP-1B, and Chk-1. We observe statistically significant correlation to experimentally measured potencies and report correlation coefficients for the three proteins in the range 0.72-0.83. The htMM-PBSA calculations illustrate the feasibility of procedural automation of physics-based scoring calculations to produce rank-ordered binding-potency estimates for protein-ligand complexes, with sufficient throughput for realization of practical implementation into scientist workflows in an industrial drug discovery research setting.

DrugBank Data that Cites this Article

Binding Properties
DrugTargetPropertyMeasurementpHTemperature (°C)
2-(Oxalyl-Amino)-4,5,6,7-Tetrahydro-Thieno[2,3-C]Pyridine-3-Carboxylic AcidTyrosine-protein phosphatase non-receptor type 1Ki (nM)50118.72N/AN/ADetails
2-[(7-HYDROXY-NAPHTHALEN-1-YL)-OXALYL-AMINO]-BENZOIC ACIDTyrosine-protein phosphatase non-receptor type 1Ki (nM)25118.86N/AN/ADetails
2-[{4-[(2S)-2-{[(Allyloxy)carbonyl]amino}-3-({4-[3-hydroxy-2-(methoxycarbonyl)phenoxy]butyl}amino)-3-oxopropyl]phenyl}(carboxycarbonyl)amino]benzoic acidTyrosine-protein phosphatase non-receptor type 1Ki (nM)125.89N/AN/ADetails
2-{[4-(2-Acetylamino-2-pentylcarbamoyl-ethyl)-naphthalen-1-YL]-oxalyl-amino}-benzoic acidTyrosine-protein phosphatase non-receptor type 1Ki (nM)630.96N/AN/ADetails
5-(2-Fluoro-5-{(1E)-3-[3-hydroxy-2-(methoxycarbonyl)phenoxy]-1-propen-1-yl}phenyl)-1,2-oxazole-3-carboxylic acidTyrosine-protein phosphatase non-receptor type 1Ki (nM)6309.57N/AN/ADetails
6-(N-Phenylcarbamyl)-2-NaphthalenecarboxamidineUrokinase-type plasminogen activatorKi (nM)630.96N/AN/ADetails
6-[(Z)-AMINO(IMINO)METHYL]-N-[3-(CYCLOPENTYLOXY)PHENYL]-2-NAPHTHAMIDEUrokinase-type plasminogen activatorKi (nM)25.12N/AN/ADetails
6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-NaphthamideUrokinase-type plasminogen activatorKi (nM)0.631N/AN/ADetails
6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-NaphthalenecarboxamidineUrokinase-type plasminogen activatorKi (nM)25.12N/AN/ADetails
6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-NaphthalenecarboxamidineUrokinase-type plasminogen activatorKi (nM)50.12N/AN/ADetails
6-[N-(4-(Aminomethyl)Phenyl)Carbamyl]-2-NaphthalenecarboxamidineUrokinase-type plasminogen activatorKi (nM)39.81N/AN/ADetails
6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-NaphthalenecarboxamidineUrokinase-type plasminogen activatorKi (nM)6.31N/AN/ADetails
7-Methoxy-8-[1-(Methylsulfonyl)-1h-Pyrazol-4-Yl]Naphthalene-2-CarboximidamideUrokinase-type plasminogen activatorKi (nM)630.96N/AN/ADetails
8-(Pyrimidin-2-Ylamino)Naphthalene-2-CarboximidamideUrokinase-type plasminogen activatorKi (nM)31.62N/AN/ADetails
AmilorideUrokinase-type plasminogen activatorKi (nM)2511.89N/AN/ADetails
Compound 5, 2-(Naphthalen-1-Yl-Oxalyl-Amino)-BenzoicacidTyrosine-protein phosphatase non-receptor type 1Ki (nM)158489.32N/AN/ADetails
Trans-6-(2-Phenylcyclopropyl)-Naphthalene-2-CarboxamidineUrokinase-type plasminogen activatorKi (nM)1258.93N/AN/ADetails